Renaissance Technologies’s Landos Biopharma, Inc. Common Stock LABP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-18,890
| Closed | -$406K | – | 4114 |
|
|
2024
Q1 | $406K | Buy |
18,890
+7,630
| +68% | +$164K | ﹤0.01% | 2957 |
|
|
2023
Q4 | $41K | Buy |
11,260
+1,000
| +10% | +$3.64K | ﹤0.01% | 3490 |
|
|
2023
Q3 | $40K | Buy |
+10,260
| New | +$40K | ﹤0.01% | 3437 |
|
|
2023
Q2 | – | Sell |
-7,920
| Closed | -$24K | – | 4419 |
|
|
2023
Q1 | $24K | Sell |
7,920
-4,620
| -37% | -$14K | ﹤0.01% | 3802 |
|
|
2022
Q4 | $63K | Sell |
12,540
-13,330
| -52% | -$67K | ﹤0.01% | 3752 |
|
|
2022
Q3 | $168K | Sell |
25,870
-13,003
| -33% | -$84.4K | ﹤0.01% | 3438 |
|
|
2022
Q2 | $283K | Buy |
38,873
+4,823
| +14% | +$35.1K | ﹤0.01% | 3485 |
|
|
2022
Q1 | $502K | Buy |
34,050
+16,940
| +99% | +$250K | ﹤0.01% | 3191 |
|
|
2021
Q4 | $821K | Buy |
17,110
+16,020
| +1,470% | +$769K | ﹤0.01% | 2790 |
|
|
2021
Q3 | $159K | Buy |
+1,090
| New | +$159K | ﹤0.01% | 3252 |
|